| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.1× | −1.7× | |
| Price / Book | 0.2× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −0.1× | −1.6× | |
| EV / EBITDA | 0.5× | −1.2× | |
| Earnings yield | −900.6% | −14.3% | |
| Free cash flow yield | −887.6% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,302.37 |
| +5.00% |
| $1.23T |
| 56.6× |
| 77.8% |
| +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $260.17 | +2.51% | $626.98B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.62 | +2.10% | $510.03B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $415.40 | +2.09% | $372.86B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.92 | +3.68% | $367.41B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.04 | +1.89% | $282.13B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.20 | +2.59% | $260.86B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.43 | +0.74% | $253.07B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.21 | +2.18% | $234.75B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.70 | +2.37% | $194.3B | 22.3× | 37.5% | +29.9% |
